DNMT3B and embryonal carcinoma: The effectiveness of 5-azacytidine is particularly noted in cases with elevated DNMT3B expression, suggesting its potential utility in managing TGCT, especially the highly aggressive non-seminomatous type, embryonal carcinoma, known for its high DNMT3B enzyme levels [99].